ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  American Journal of Medicine

• Publication date

  1994-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(94)90022-1PMID 8059778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin-Konversionsenzym-Hemmer zur Behandlung der Angina pectoris

  2008cited by this paper
• [Captopril in acute myocardial infarct: its effect on infarct size and arrhythmias].

  2008cited by this paper
• Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat

  2005cited by this paper
• Lies, damned lies--or statistics?

  1992cited by this paper
• [The angiotensin-converting enzyme inhibitor in the treatment of angina pectoris].

  1992cited by this paper
• Angiotensin converting enzyme inhibitors and the cardiovascular system.

  1992cited by this paper
• Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.

  1992cited by this paper
• Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.

  1991cited by this paper
• Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

  1991cited by this paper
• Bronchial hyperreactivity and cough induced by angiotensin-converting enzyme-inhibitor therapy.

  1990cited by this paper
• Antihypertensive Treatment: Considerations Beyond Blood Pressure Control

  1989cited by this paper
• A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.

  1989cited by this paper
• Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.

  1988cited by this paper
• Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors

  1988cited by this paper
• Preoperative biochemical screening

  1988cited by this paper
• Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.

  1988cited by this paper
• Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy.

  1987cited by this paper
• Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.

  1987cited by this paper
• Insulin resistance in essential hypertension.

  1987cited by this paper
• Effects of captopril on the physical work capacity of normotensive patients with stable-effort angina pectoris.

  1987cited by this paper
• Cough associated with captopril and enalapril.

  1987cited by this paper
• Comparison of the efficacy of an ACE-inhibitor and a calcium channel blocker in hypertensive asthmatics. A preliminiary report.

  1986cited by this paper
• Effects of captopril on hemodynamics and blood gases in chronic obstructive lung disease with pulmonary hypertension.

  1986cited by this paper
• Captopril and bronchial reactivity.

  1986cited by this paper
• Urinary 6-keto-PGF1 alpha after captopril and indomethacin: possible contribution of PGI2 to the antihypertensive mechanism of ACE inhibitors.

  1985cited by this paper
• Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.

  1985cited by this paper
• Captopril for the Treatment of Patients with Hypertension and Peripheral Vascular Disease

  1985cited by this paper
• MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

  1985cited by this paper
• Antihypertensive treatment and serum lipoproteins.

  1985cited by this paper
• Captopril in heart failure. A double blind controlled trial.

  1984cited by this paper
• Acute effects of captopril on the coronary circulation of patients with hypertension and angina.

  1984cited by this paper
• Gastric mucosal prostaglandin E levels in patients with gastric ulcer disease and carcinoma

  1982cited by this paper
• Gastric mucosal prostaglandin E levels in patients with gastric ulcer disease and carcinoma.

  1982cited by this paper
• Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up.

  1982cited by this paper
• Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.

  1980cited by this paper
• The Effect of Converting Enzyme Inhibition with SQ20,881 on Plasma and Urinary Kinins, Prostaglandin E, and Angiotensin II in Hypertensive Man

  1979cited by this paper
• Letter: Herpes simplex.

  1975cited by this paper
• Letter: Transfer-factor therapy of chronic active hepatitis.

  1974cited by this paper

• Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.

  2021cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper
• 45 – Aorta and Peripheral Arterial Disease in Hypertension

  2018cites this paper
• Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials

  2017cites this paper
• The Roles of ACE Inhibitors in Lower Extremity Peripheral Artery Disease

  2016cites this paper
• Atherosclerotic Peripheral Artery Disease: Clinical Management

  2014cites this paper
• Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication.

  2013influential citation
• Randomized clinical trial of angiotensin‐converting enzyme inhibitor, ramipril, in patients with intermittent claudication

  2013cites this paper
• Angiotensin-Converting Enzyme Inhibitors for Intermittent Claudication Associated With Peripheral Arterial Disease

  2013cites this paper
• Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.

  2013cites this paper
• Effect of Ramipril on Walking Times and Quality of Life Among Patients With Peripheral Artery Disease and Intermittent Claudication

  2013cites this paper
• Chapter 19 – Medical Treatment of Peripheral Artery Disease

  2013cites this paper
• Treatment of hypertension in peripheral arterial disease.

  2013cites this paper
• Perindopril

  2012cites this paper
• Perindopril

  2012cites this paper
• ACE inhibitors for the treatment of hypertension drug selection by means of the SOJA method.

  2011cites this paper
• Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease? A systematic review and meta-analysis of randomised controlled trials.

  2011cites this paper
• Hochdruck und Gefäßsystem

  2010cites this paper
• Angiotensin converting enzyme and vascular endothelial growth factor responses to exercise training in claudicants: the role of ace inhibition

  2009cites this paper
• Management Of Hypertension With Concomitant Coronary Artery Disease: Results From The Imperial Study-4

  2009cites this paper
• Management of hypertension in peripheral arterial disease.

  2008cites this paper
• Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension.

  2008cites this paper
• A systematic review of the blood pressure lowering efficacy of ACE inhibitors and angiotensin receptor blockers for primary hypertension

  2008cites this paper
• chapter 18 – Medical Treatment of Peripheral Arterial Disease

  2006cites this paper
• Antihypertensive Utility of Perindopril in a Large, General Practice‐Based Clinical Trial

  2005cites this paper
• Systematic review on urine albumin testing for early detection of diabetic complications.

  2005cites this paper
• Chapter 54 – Ischemic Heart Disease

  2005cites this paper
• Antihypertensive Utility of Perindopril in a Large, General Practice‐Based Clinical Trial

  2004cites this paper
• Dysphonia secondary to perindopril treatment.

  2003cites this paper
• [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].

  2003cites this paper
• Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy.

  2003cites this paper
• Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.

  2003cites this paper
• Inhibitory konwertazy angiotensyny w leczeniu choroby niedokrwiennej serca - w oczekiwaniu na EUROPĘ

  2003cites this paper
• Perindopril: an updated review of its use in hypertension.

  2001cites this paper
• Efficacy of perindopril in the treatment of systemic hypertension.

  2001cites this paper
• PerindoprilReview of Its Use in Hypertension

  2001cites this paper
• Safety profile of perindopril.

  2001cites this paper
• Blood pressure control, microalbuminuria and cardiovascular risk in Type 2 diabetes mellitus

  1999cites this paper
• NSAIDs and Blood Pressure

  1998cites this paper
• NSAIDs and Increased Blood Pressure

  1997cites this paper